Condition: Mucositis Oral · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
To assess the efficacy of preventive Low-Level Laser Therapy (LLLT) for reducing the incidence of WHO's grade 3-4 oral mucositis in children and young adults receiving chemotherapy regimens associated with a high rate of mucositis: conventional chemotherapy or High Dose Chemotherapy (HDC) conditioning regimens with Hematological Stem Cell Transplantation (HSCT).
This description comes directly from the study's public registry record.
Léa Guerrini-Rousseau, MD · +33 (0)1 42 11 67 41 · lea.guerrini-rousseau@gustaveroussy.fr
Jérémy MIONE, MS · +33 (0)1 42 11 42 11 · jeremy.mione@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Gustave Roussy | Villejuif, Val de Marne, France | Recruiting |
| Centre Oscar Lambret | Lille, France | Recruiting |
| Hôpital Robert Debré | Paris, France | Recruiting |
| Institut Curie | Paris, France | Recruiting |
| CHU de Rennes | Rennes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03983369